T Rowe Price Grp SEC Filings

Sandra S. Wijnberg, a director of T. Rowe Price Group, Inc. (TROW), reported an acquisition of common stock on 09/29/2025. The Form 4 shows 146.3122 shares were credited to her account as fully vested dividend reinvestment shares at a price of $103.52 per share under the 2017 Non-Employee Director Equity Plan. After the transaction she beneficially owned 29,036.4845 shares directly. The form was signed by Kathryn L. Reilly as power of attorney on 09/30/2025 and the filing notes the shares resulted from dividends declared by the issuer.

The reporting person, Robert F. MacLellan, a director of T. Rowe Price Group, Inc. (TROW), received 161.0154 shares of common stock on 09/29/2025 under the company's 2017 Non-Employee Director Equity Plan as fully vested dividend reinvestment shares. After this automatic crediting the report shows beneficial ownership of 47,495.6698 shares. The transaction price listed is $103.52 per share, and the Form 4 was signed by an assistant corporate secretary acting under power of attorney on 09/30/2025. The filing reflects a routine, plan-driven reinvestment of dividends rather than an open-market purchase or sale.

Dina Dublon, a director of T. Rowe Price Group, Inc. (TROW), reported an acquisition of common stock on 09/29/2025 under the company’s 2017 Non-Employee Director Equity Plan. The filing states 112.9829 shares were credited as fully vested dividend reinvestment shares at a reported price of $103.52 per share. After the transaction the report lists 13,273.4251 shares beneficially owned and notes an indirect ownership of 1,890 shares held by The Dina Dublon Family Trust.

The form is signed by a corporate secretary on behalf of Ms. Dublon on 09/30/2025 and explicitly ties the shares to dividend reinvestment credited under the director equity plan.

Reporting person: Robert J. Stevens, Director of Price T Rowe Group Inc. (TROW).

On 09/29/2025 he acquired 258.7599 shares of the issuer's common stock at a price of $103.52 per share. After the transaction he beneficially owned 21,350.751 shares. The filing states the shares were issued under the 2017 Non-Employee Director Equity Plan in connection with declared dividends: some shares were credited as fully vested dividend-reinvestment shares and some will accrue and vest when the underlying grant vests. The form is signed by Kathryn L. Reilly as POA on 09/30/2025.

Robert F. MacLellan, a director of T. Rowe Price Group (TROW), reported option exercise and a subsequent sale on 09/22/2025. He exercised stock options to acquire 4,417 shares at a conversion/exercise price of $72.8212 per share, and immediately or subsequently sold 3,090 of those shares at prices in the $104.95 to $105.04 range (reported average price shown as $105.0052). After these transactions his beneficial ownership is reported as 47,334.6544 shares. The filing includes a note that the seller will provide a breakdown of shares sold at each separate price on request.

Price T Rowe Group insider intends to sell 3,090 common shares acquired through a stock option exercise on 09/22/2025. The sale is to be executed through Morgan Stanley Smith Barney LLC on NASDAQ, with an aggregate market value reported as $324,466.07 and the company showing 219,715,241 shares outstanding. The filer reports no securities sold in the past three months and indicates payment was made in cash. The notice includes the standard representation that the seller is not aware of any undisclosed material adverse information about the issuer.

T. Rowe Price Group, Inc. disclosed a strategic collaboration with Goldman Sachs by press release dated September 4, 2025. The company filed the announcement on a Form 8-K and attached the press release as Exhibit 99.1, incorporating that document by reference into the Current Report. The filing is signed by David Oestreicher, Vice President, General Counsel and Secretary.

The notice contains no financial figures, transaction terms, or implementation details; it solely reports the collaboration and the existence of the press release as an exhibit.

T. Rowe Price Group’s Q2-25 10-Q shows modest earnings growth driven by investment gains despite continued net outflows and higher operating costs.

• Revenue: Q2 net revenues were $1.72 bn, essentially flat YoY (-0.6%), as advisory fees held steady while performance-based fees fell 62% to $6.4 mn.
• Expenses: Operating expenses rose 6.5% to $1.25 bn, led by compensation (+10%) and tech/occupancy (+12%).
• Profitability: Net operating income declined 15% to $478 mn, but strong investment gains (+113% YoY) lifted non-operating income to $236 mn. Net income attributable to TROW grew 4.5% to $505 mn; diluted EPS advanced to $2.24 from $2.11.
• Six-month view: Revenues were flat at $3.49 bn; net income fell 5.8% to $996 mn as expense growth outpaced revenues.
• Balance sheet: Cash & equivalents increased 15% since year-end to $3.06 bn; total equity reached $10.56 bn. Operating lease liabilities and deferred comp liabilities both rose.
• AUM: Assets under management closed at $1.68 tn, up 7% QoQ on $125 bn market appreciation but faced $14.9 bn net outflows (-$23.5 bn YTD). Multi-asset target-date AUM hit $520 bn.
• Capital returns: $328 mn of buybacks and $286 mn dividends in Q2; quarterly dividend raised to $1.27/share.

Management sees no material impact from the newly enacted One Big Beautiful Bill Act tax changes and still values the OHA earn-out at zero.